
Beijing SL Pharmaceutical Co., Ltd.
SZSE:002038.SZ
Overview | Financials
Company Name | Beijing SL Pharmaceutical Co., Ltd. |
Symbol | 002038.SZ |
Currency | CNY |
Price | 11.69 |
Market Cap | 12,009,721,687 |
Dividend Yield | 1.18% |
52-week-range | 8.13 - 16.09 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Mingbo Xu |
Website | https://www.slpharm.com.cn |
An error occurred while fetching data.
About Beijing SL Pharmaceutical Co., Ltd.
Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, produces, and markets genetic engineering and related drugs in the People's Republic of China and internationally. The company's finished formulations includes temozolomide; arsenic trioxide; lenalidomide; docetaxel; paclitaxel; filgrastim Recombinant human granulocyte colony-stimulating factor; recombinant human interleukin-11; recombinant human interleukin-2; thymopentin;
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD